About
Professor David Baker is a leading neuroimmunologist at the Blizard Institute, part of Queen Mary University of London. He has dedicated over three decades to translational research in multiple sclerosis (MS), bridging basic science and clinical applications through collaborations with Professors Gavin Giovannoni and Klaus Schmierer.
- Education: B.Sc. in Zoology from Bedford College (1983), Ph.D. in immunology from the University of London (1987)
- Academic Timeline: Postdoctoral fellowships (1987-1999), University College London (1999-2004), Professor since 2004
His research focuses on experimental models of MS, autoimmune tolerance, and disease-modifying therapies targeting:
- Memory B cell mechanisms
- Neuroprotection strategies
- Symptomatic control of spasticity with cannabinoids
- Anti-drug antibody responses
Recent publications highlight his work on:
- Microglial activation in neurodegenerative diseases
- Vaccine response dynamics in MS patients
- Immunogenicity of biologics
- Cannabinoid-based therapeutics
As founder of Canbex Therapeutics, he pioneered the first clinical trial for cannabis-based MS treatment. Current work examines SARS-CoV-2 interactions with MS immunopathology.
0Publications listed
Find David Baker elsewhere
Related Searches
You Might Also Like
Gavin GiovannoniQueen Mary University of London · Professor
Ratna KapurQueen Mary University of London · Professor
Renisa MawaniQueen Mary University of London · Professor
Nadera Shalhoub-KevorkianQueen Mary University of London · Professor
Peter McOwanQueen Mary University of London · Professor- AAisha AbuelmaattiQueen Mary University of London · Senior Lecturer